Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria
Open Access
- 29 January 2008
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 83 (6), 485-490
- https://doi.org/10.1002/ajh.21162
Abstract
Pulmonary artery systolic hypertension is common and associated with increased mortality among adult sickle cell disease (SCD) patients in the United States. Although the prevalence of SCD is highest in sub‐Saharan Africa, the frequency of pulmonary artery systolic hypertension and the risk factors for the development of pulmonary hypertension have not been reported from Africa. We studied 208 hydroxyurea naïve Nigerian SCD patients at steady state and 94 healthy controls. Pulmonary artery systolic hypertension was defined prospectively as tricuspid regurgitant jet velocity ≥2.5 m/sec. Results were compared with a previously published US prospective SCD cohort. Only 7% of Nigerians compared with 46% of US adults with SCD were >35 years. Tricuspid regurgitant jet velocity was ≥2.5 m/sec in 25% of Nigerian SCD patients. Higher jet velocity was associated with greater serum globulin (P = 0.002), blood urea nitrogen (P = 0.019) and lactate dehydrogenase concentrations (P = 0.026) and with inability to walk >300 m in 6 min (P = 0.042). Compared with the US cohort, Nigerian patients had more hemolysis as indicated by lower hemoglobin and higher lactate dehydrogenase concentrations (P ≤ 0.003). Pulmonary hypertension is common among Nigerian SCD patients. The public health implication of this finding is significant considering the potential number of individuals at risk for this complication. Better understanding of the long term outcome of pulmonary hypertension and causes of death in SCD and the institution of preventive measures are major public health challenges for Africa. The inclusion of African sites in sickle cell pulmonary hypertension clinical trials should be encouraged. Am. J. Hematol., 2008.Keywords
This publication has 24 references indexed in Scilit:
- Sickle cell disease and pulmonary hypertension in Africa: A global perspective and review of epidemiology, pathophysiology, and managementAmerican Journal of Hematology, 2007
- Relative systemic hypertension in patients with sickle cell disease is associated with risk of pulmonary hypertension and renal insufficiencyAmerican Journal of Hematology, 2007
- Diastolic Dysfunction Is an Independent Risk Factor for Death in Patients With Sickle Cell DiseaseJournal of the American College of Cardiology, 2007
- Deconstructing sickle cell disease: Reappraisal of the role of hemolysis in the development of clinical subphenotypesBlood Reviews, 2006
- Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic functionBritish Journal of Haematology, 2006
- Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of CardiologyJournal of the American Society of Echocardiography, 2005
- Pulmonary hypertension in sickle cell diseaseAmerican Journal Of Medicine, 2004
- Hepatitis C and the heart: to beat or not to beatInternational Journal of Cardiology, 2004
- Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell DiseaseNew England Journal of Medicine, 2004
- Fair Benefits for Research in Developing CountriesScience, 2002